Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Patrick Grierson, M.D., Ph.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis, Missouri, United States
Adeel Khan, M.D.Benjamin Tan, M.D.Carl DeSelm, M.D., Ph.D.Dan Mullady, M.D.David DeNardo, Ph.D.Dominic Sanford, M.D.Esther Lu, Ph.D.Gabriel Lang, M.D.Julie Schwarz, M.D., Ph.D.Kian-Huat Lim, M.D., Ph.D.Koushik Das, M.D.Liang I-Kang, M.D., Ph.D.Majella Doyle, M.D.Natasha Leigh-Matijakovich, M.D.Nikolaos Trikalinos, M.D.Olivia Aranha, M.D.Pamela Samson, M.D.Patrick Grierson, M.D., Ph.D.Rama Suresh, M.D.Roheena Panni, M.D., Ph.D.Vladimir Khushnir, M.D.William Chapman, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Apr 2026
- Primary completion
- 30 Apr 2030
- Completion
- 30 Apr 2030
- Last update posted
- 15 Apr 2026
- Registered enrollment
- 36
- Registry id
- NCT07126158
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.